Personal profile
Biography
Kerry Millington is a global health researcher with over 20 years of experience in world leading academic organisations. She is passionate about improving the health and wellbeing of individuals and communities through research and innovative solutions. Kerry has built strong, professional relationships with colleagues and stakeholders to support the use of knowledge, evidence and learning for informed decision-making for positive change in policy and practice, maximising research impact for sustainable development.
Kerry is currently Director of the Centre for Tuberculosis Research bringing multidisciplinary researchers across Liverpool School of Tropical Medicine (LSTM) and their partners together to improve health, social and economic outcomes for people affected by tuberculosis through research, partnership, and education.
Specifically, within the Leaving no on-one behind: Gendered pathways to health for TB programme, funded with UK aid, she is leading on working with partners in Africa to develop and deliver a strategy for maximising the impact of research from the programme for gender-equitable access to tuberculosis care.
Kerry also works on the Knowledge, Evidence and Learning for Development and Diplomacy programme supporting the use of learning and evidence to improve the impact of development and diplomacy policy and programmes. Also funded with UK aid, this programme is designed to assist the Foreign, Commonwealth and Development Office and other UK government departments and partners to be innovative and responsive to rapidly changing and complex development and diplomacy challenges. This replaces and builds on the previous K4D and HEART programmes which Kerry worked on providing knowledge and consultancy services from the wide-ranging expertise of LSTM and its networks on health, nutrition and education.
Research interests
Kerry’s research has ranged from discovery to delivery, from developing innovative diagnostic tests to ensuring equitable access to health services. She has a particular interest in the demand and supply of high-quality evidence, including real-world evidence, and in strengthening capacity, systems, and cross-sector partnerships to improve evidence-informed, person-centred care. As an experienced and dynamic leader, she is eager to expand the research portfolio on what works and factors that influence evidence use in decision-making bringing together learning, evaluation and practice across disciplines and sectors.
Kerry joined LSTM in 2010 from Imperial College London where she worked as a Postdoctoral Research Associate on a variety of projects including expanding the evidence-base of the diagnostic accuracy and prognostic value of new blood tests for diagnosing mycobacterium tuberculosis infection. She completed her DPhil investigating T cell responses to mycobacterium tuberculosis infection at University of Oxford in 2006 and a BSc Hons in Biochemistry at University of Leeds and Pennsylvania State University in 2001.
Fingerprint
Dive into the research topics where Kerry Millington is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Addressing the growing TB disease burden in England
Millington, K., Nightingale, B., Walker, N., Ringwald, B., Cantillon, D., Karmadwala, F. & Wingfield, T., 1 May 2025, In: The Lancet. Respiratory medicine. 13, 5, p. 387-389 3 p.Research output: Contribution to journal › Comment/debate
Open AccessFile2 Citations (Scopus) -
Gender-Equitable Access to Tuberculosis Care and Prevention in Malawi: A Political Economy Analysis: A Political Economy Analysis
Mosiwa, B. A., Abdullahi, L., Zulu, E., Millington, K. & El Hajj, T., 4 Apr 2025, In: World Medical & Health Policy. 17, 3, p. 306-318 13 p.Research output: Contribution to journal › Article › peer-review
1 Citation (Scopus) -
Drug-resistant tuberculosis treatments, the case for a phase III platform trial.
Yates, T. A., Barnes, S., Dedicoat, M., Kon, O. M., Kunst, H., Lipman, M., Millington, K., Nunn, A. J., Phillips, P. P. J., Potter, J. L. & Squire, B., 1 Sept 2024, In: Bulletin of the World Health Organization. 102, 9, p. 657-664 8 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile3 Citations (Scopus) -
Gendered gaps to tuberculosis prevention and care in Kenya: a political economy analysis study.
Abdullahi, L. H., Oketch, S., Komen, H., Mbithi, I., Millington, K., Mulupi, S., Chakaya, J. & Zulu, E. M., 3 Apr 2024, In: BMJ Open. 14, 4, p. e077989 e077989.Research output: Contribution to journal › Article › peer-review
Open AccessFile3 Citations (Scopus) -
The 2023 UN high-level meeting on tuberculosis: renewing hope, momentum, and commitment to end tuberculosis
Millington, K., White, R. G., Lipman, M., McQuaid, C. F., Hauser, J., Wooding, V., Potter, J., Abubakar, I. & Wingfield, T., 1 Jan 2024, In: The Lancet Respiratory Medicine. 12, 1, p. 10-13 4 p.Research output: Contribution to journal › Comment/debate
Open AccessFile16 Citations (Scopus)